Clinical Trial

Preventing Chemotherapy-induced Peripheral Neuropathy Using PRESIONA Exercise Program

Study acronym: PRESIONA
Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this study is to determinate if therapeutic exercise with blood flow restriction (BFR) during neoadjuvant chemotherapy potentialy neurotoxic could prevent the onset of chemotherapy induced peripheral neuropathy (CIPN) comparing to usual care.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2020-12-01; most recent amendment 2025-11-15.
Status change: Not Yet Recruiting → Recruiting 2022-03-08
Trial Details
NCT Number NCT04652609
Lead Sponsor Universidad de Granada
Conditions Breast Neoplasm
Enrollment 25 participants
Start Date 2021-01-01
Primary Completion 2025-01-01 (estimated)
Study Completion 2027-01-01 (estimated)
Updated on ClinicalTrials.gov 2025-11-18